Amgen
AMGN
$265.51
Share price
-0.66%
Change (1 day)
7.03%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
P/S ratio for Amgen (AMGN)
P/S ratio as of April 2024 (TTM): 5.05
According to Amgen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.0476. At the end of 2023 the company had a P/S ratio of 5.47.
P/S ratio history for Amgen from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.47 | 2.71% |
| 2022 | 5.32 | 9.15% |
| 2021 | 4.88 | -7.35% |
| 2020 | 5.26 | -13.73% |
| 2019 | 6.10 | 18.24% |
| 2018 | 5.16 | -6.58% |
| 2017 | 5.52 | 16.78% |
| 2016 | 4.73 | -16.27% |
| 2015 | 5.65 | -6.41% |
| 2014 | 6.04 | 30.98% |
| 2013 | 4.61 | 22.07% |
| 2012 | 3.78 | 4.54% |
| 2011 | 3.61 | 6.26% |
| 2010 | 3.40 | -11.58% |
| 2009 | 3.84 | -4.61% |
| 2008 | 4.03 | 17.93% |
| 2007 | 3.42 | -38.78% |
| 2006 | 5.58 | -28.11% |
| 2005 | 7.77 | 1.36% |
| 2004 | 7.66 | -19.29% |
| 2003 | 9.49 | -17.08% |
| 2002 | 11.4 | -23.23% |
| 2001 | 14.9 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.82 | -24.25% | 🇺🇸 USA |
 Pfizer PFE | 2.51 | -50.31% | 🇺🇸 USA |
 AbbVie ABBV | 5.27 | 4.41% | 🇺🇸 USA |
 Eli Lilly LLY | 20.9 | 314.41% | 🇺🇸 USA |
 Biogen BIIB | 2.91 | -42.38% | 🇺🇸 USA |
 Gilead Sciences GILD | 3.12 | -38.27% | 🇺🇸 USA |
 Illumina ILMN | 4.28 | -15.13% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.18 | -56.72% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.20 | -56.49% | 🇬🇧 UK |